In-vitro Activity of Delpazolid and Comparator Agents Against Methicillin-resistant Staphylococcus aureus Involved in Bloodstream Infection

Ann Lab Med. 2023 Jul 1;43(4):389-391. doi: 10.3343/alm.2023.43.4.389. Epub 2023 Feb 24.

Authors

Jeong Su Park¹, Yun Jung Choi², Kyungmi Kwon², Seong Jin Choi², Song Mi Moon², Kyoung-Ho Song², Eu Suk Kim², Kyoung Un Park¹, Hong Bin Kim²

Affiliations

¹ Department of Laboratory Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
² Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.

No abstract available

Publication types

Letter

MeSH terms

Anti-Bacterial Agents / pharmacology
Cross Infection*
Humans
Methicillin-Resistant Staphylococcus aureus*
Microbial Sensitivity Tests
Oxazolidinones* / pharmacology
Sepsis*
Staphylococcal Infections* / diagnosis
Staphylococcal Infections* / drug therapy

Substances

delpazolid
Oxazolidinones
Anti-Bacterial Agents

Grants and funding

RESEARCH FUNDING This work was supported by LegoChem Biosciences (grant No. 06-2022-0028).